Updated:
Cell Innovation Partners
Cell Innovation Partners is a Japan-based private equity manager pursuing venture investments.
Cell Innovation Partners
Cell Innovation Partners is a healthcare venture fund established by Reprocell and Shinsei Bank Group. It focuses on regenerative medicine and next-generation stem cell therapies. The fund has made 3 investments, including a Series B - II investment in Symic Bio on April 25, 2019.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
Japan
City
Kanagawa
Corporate office
Kanagawa, Japan
Sector focus
Frequently asked questions
What is the investment focus of Cell Innovation Partners?
The firm lists a venture generalist strategy.
Where is Cell Innovation Partners headquartered?
Records place the firm in Kanagawa, Japan.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: